Epidemiology and Natural History of Human Papillomavirus Infections and Type-Specific Implications in Cervical Neoplasia

Vaccine

Volumn 26, Issue SUPPL. 10, 2008, Pages

  Bosch, F Xavier ^a   Burchell, Ann N ^b   Schiffman, Mark ^c   Giuliano, Anna R ^d   de Sanjose, Silvia ^a,e   Bruni, Laia ^a   Tortolero Luna, Guillermo ^f   Kjaer, Susanne Kruger ^g   Muñoz, Nubia ^a,h  

^a CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^b MCGILL UNIVERSITY   (Canada)

^c NATIONAL CANCER INSTITUTE   (United States)

^d H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^e CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^f UNIVERSITY OF PUERTO RICO   (Puerto Rico)

^g INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^h Instituto Nacional de Cancerología   (Colombia)

Author keywords

Cervical neoplasia; Epidemiology; HPV; Sexual behavior

Indexed keywords

VIRUS DNA;

ARTICLE; CANCER PREVENTION; DISEASE COURSE; FEMALE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; INFECTION RISK; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; VIRUS CARCINOGENESIS; VIRUS INFECTION; VIRUS TRANSMISSION; VIRUS TYPING; WART VIRUS;

FEMALE; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RISK FACTORS; SEXUAL BEHAVIOR; UTERINE CERVICAL NEOPLASMS;

EID: 50849126768     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.05.064     Document Type: Article

References (51)

1. de Sanjose S., Diaz M., Castellsague X., Clifford G., Bruni L., Muñoz N., et al. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis 7 7 (2007) 453-459
2. Castellsague X, de Sanjose S, Aguado T, Louie KS, Bruni L, Muñoz J, et al., editors. HPV and Cervical Cancer in the World. 2007 Report. WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre). Vaccine 2007; 25(Suppl 3). Available at www.who.int/hpvcentre/en/. (last accessed: April 2008).
3. Clifford G.M., Gallus S., Herrero R., Muñoz N., Snijders P.J., Vaccarella S., et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 366 9490 (2005) 991-998
4. Castle P.E., Jeronimo J., Schiffman M., Herrero R., Rodriguez A.C., Bratti M.C., et al. Age-related changes of the cervix influence human papillomavirus type distribution. Cancer Res 66 2 (2006) 1218-1224
5. Franceschi S., Herrero R., Clifford G.M., Snijders P.J., Arslan A., Anh P.T., et al. Variations in the age-specific curves of human papillomavirus prevalence in women worldwide. Int J Cancer 119 11 (2006) 2677-2684
6. Muñoz N., Mendez F., Posso H., Molano M., van den Brule A.J., Ronderos M., et al. Incidence, duration, and determinants of cervical human papillomavirus infection in a cohort of Colombian women with normal cytological results. J Infect Dis 190 12 (2004) 2077-2087
7. Wellings K., Collumbien M., Slaymaker E., Singh S., Hodges Z., Patel D., et al. Sexual behaviour in context: a global perspective. Lancet 368 9548 (2006) 1706-1728
8. Smith J.S., Lindsay L., Hoots B., Keys J., Franceschi S., Winer R., et al. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer 121 3 (2007) 621-632
9. Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V., et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189 1 (1999) 12-19
10. Chan P.K., Cheung T.H., Tam A.O., Lo K.W., Yim S.F., Yu M.M., et al. Biases in human papillomavirus genotype prevalence assessment associated with commonly used consensus primers. Int J Cancer 118 1 (2006) 243-245
11. Quint W.G., Pagliusi S.R., Lelie N., de Villiers E.M., and Wheeler C.M. Results of the first World Health Organization international collaborative study of detection of human papillomavirus DNA. J Clin Microbiol 44 2 (2006) 571-579
12. Clifford G.M., Smith J.S., Aguado T., and Franceschi S. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br J Cancer 89 1 (2003) 101-105
13. Muñoz N., Bosch F.X., Castellsague X., Diaz M., de Sanjose S., Hammouda D., et al. Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer 111 2 (2004) 278-285
14. Clifford G.M., Smith J.S., Plummer M., Muñoz N., and Franceschi S. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 88 1 (2003) 63-73
15. de Sanjose S, Quint W, Klaustenmeier J, Lloveras B, Brunsveld JP, Font R, et al. HPV type distribution in invasive cervical cancer: The worldwide perspective. Proceedings of the 24th International Papillomavirus Conference and Clinical Workshop, Beijing, China, 2007. Abstracts book. Abstract 2C-01.
16. Castellsague X., Diaz M., de Sanjose S., Muñoz N., Herrero R., Franceschi S., et al. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. J Natl Cancer Inst 98 5 (2006) 303-315
17. Parkin DM, Whelan SLFJ, Teppo L, Thomas DB. Cancer Incidence in Five Continents, Volume VIII. IARC Scientific Publications No. 155. Lyon: IARC Press, 2003.
18. Stevenson B, Wolfers J. Marriage and Divorce: Changes and their Driving Forces. J Economic Perspectives, American Economic Association 2006; 21(2):27-52.
19. Bearinger L.H., Sieving R.E., Ferguson J., and Sharma V. Global perspectives on the sexual and reproductive health of adolescents: patterns, prevention, and potential. Lancet 369 9568 (2007) 1220-1231
20. Low N., Broutet N., Adu-Sarkodie Y., Barton P., Hossain M., and Hawkes S. Global control of sexually transmitted infections. Lancet 368 9551 (2006) 2001-2016
21. Morris M., Goodreau S., and Moody J. Sexual networks, concurrency and STD/HIV. In: Holmes K.K., Sparling P.E., Stamm W.E., Piot P., Wasserheit J.N., Corey L., et al. (Eds). Sexually Transmitted Diseases. 4th edition (2008), McGraw Hill Medical, New York 109-125
22. Ward H. Prevention strategies for sexually transmitted infections: importance of sexual network structure and epidemic phase. Sex Transm Infect 83 Suppl 1 (2007) i43-i49
23. Liljeros F., Edling C.R., and Nunes Amaral L.A. Sexual networks: implications for the transmission of sexually transmitted infections. Microbes Infect 5 2 (2003) 189-196
24. Liljeros F., Edling C.R., Amaral L.A., Stanley H.E., and Aberg Y. The web of human sexual contacts. Nature 411 6840 (2001) 907-908
25. Garnett G.P. The transmission dynamics of sxually transmitted infections. In: Holmes K.K., Sparling P.F., Stamm W.E., Piot P., Wasserheit J.N., Corey L., et al. (Eds). Sexually Transmitted Diseases. 4th edition (2008), McGraw Hill Medical, New York 27-39
26. Rothenberg R., and Muth S.Q. Large-network concepts and small-network characteristics: fixed and variable factors. Sex Transm Dis 34 8 (2007) 604-612
27. Bearman P.S., Moody J., and Stovel K. Chains of affection: The Structure of Adolescent Romantic and Sexual Networks. Am J Sociol 110 1 (2004) 44-91
28. Aral S.O., and Ward H. Modern day influences on sexual behavior. Infect Dis Clin North Am 19 2 (2005) 297-309
29. Gonzalez C., Ortiz M., Canals J., Muñoz L., Jarrin I., de la Hera M.G., et al. Higher prevalence of human papillomavirus infection in migrant women from Latin America in Spain. Sex Transm Infect 82 3 (2006) 260-262
30. del Amo J., Gonzalez C., Losana J., Clavo P., Muñoz L., Ballesteros J., et al. Influence of age and geographical origin in the prevalence of high risk human papillomavirus in migrant female sex workers in Spain. Sex Transm Infect 81 1 (2005) 79-84
31. Adrien A., Leaune V., Remis R.S., Boivin J.F., Rud E., Duperval R., et al. Migration and HIV: an epidemiological study of Montrealers of Haitian origin. Int J STD AIDS 10 4 (1999) 237-242
32. Rangel M.G., Martinez-Donate A.P., Hovell M.F., Santibanez J., Sipan C.L., and Izazola-Licea J.A. Prevalence of risk factors for HIV infection among Mexican migrants and immigrants: probability survey in the North border of Mexico. Salud Publica Mex 48 1 (2006) 3-12
33. Mercer A., Khanam R., Gurley E., and Azim T. Sexual risk behavior of married men and women in Bangladesh associated with husbands' work migration and living apart. Sex Transm Dis 34 5 (2007) 265-273
34. Yang X., Derlega V.J., and Luo H. Migration, behaviour change and HIV/STD risks in China. AIDS Care 19 2 (2007) 282-288
35. Zuma K., Lurie M.N., Williams B.G., Mkaya-Mwamburi D., Garnett G.P., and Sturm A.W. Risk factors of sexually transmitted infections among migrant and non-migrant sexual partnerships from rural South Africa. Epidemiol Infect 133 3 (2005) 421-428
36. Kovacic M.B., Castle P.E., Herrero R., Schiffman M., Sherman M.E., Wacholder S., et al. Relationships of human papillomavirus type, qualitative viral load, and age with cytologic abnormality. Cancer Res 66 20 (2006) 10112-10119
37. Gravitt P.E., Kovacic M.B., Herrero R., Schiffman M., Bratti C., Hildesheim A., et al. High load for most high risk human papillomavirus genotypes is associated with prevalent cervical cancer precursors but only HPV16 load predicts the development of incident disease. Int J Cancer 121 12 (2007) 2787-2793
38. Castle P.E., Sideri M., Jeronimo J., Solomon D., and Schiffman M. Risk assessment to guide the prevention of cervical cancer. Am J Obstet Gynecol 197 4 (2007) 356
39. Cox J.T., Schiffman M., and Solomon D. Prospective follow-up suggests similar risk of subsequent cervical intraepithelial neoplasia grade 2 or 3 among women with cervical intraepithelial neoplasia grade 1 or negative colposcopy and directed biopsy. Am J Obstet Gynecol 188 6 (2003) 1406-1412
40. Carreon J.D., Sherman M.E., Guillen D., Solomon D., Herrero R., Jeronimo J., et al. CIN2 is a much less reproducible and less valid diagnosis than CIN3: results from a histological review of population-based cervical samples. Int J Gynecol Pathol 26 4 (2007) 441-446
41. Stoler M.H. ASC, TBS, and the power of ALTS. Am J Clin Pathol 127 4 (2007) 489-491
42. Wheeler C.M., Hunt W.C., Schiffman M., and Castle P.E. Human papillomavirus genotypes and the cumulative 2-year risk of cervical precancer. J Infect Dis 194 9 (2006) 1291-1299
43. Trottier H., Mahmud S., Costa M.C., Sobrinho J.P., Duarte-Franco E., Rohan T.E., et al. Human papillomavirus infections with multiple types and risk of cervical neoplasia. Cancer Epidemiol Biomarkers Prev 15 7 (2006) 1274-1280
44. Garcia-Pineres A.J., Hildesheim A., Herrero R., Trivett M., Williams M., Atmetlla I., et al. Persistent human papillomavirus infection is associated with a generalized decrease in immune responsiveness in older women. Cancer Res 66 22 (2006) 11070-11076
45. Castle P.E., Schiffman M., Herrero R., Hildesheim A., Rodriguez A.C., Bratti M.C., et al. A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica. J Infect Dis 191 11 (2005) 1808-1816
46. Schiffman M., and Kjaer S.K. Chapter 2: Natural history of anogenital human papillomavirus infection and neoplasia. J Natl Cancer Inst Monogr 31 (2003) 14-19
47. Muñoz N., Bosch F.X., de Sanjose S., Tafur L., Izarzugaza I., Gili M., et al. The causal link between human papillomavirus and invasive cervical cancer: a population-based case-control study in Colombia and Spain. Int J Cancer 52 5 (1992) 743-749
48. Plummer M., Schiffman M., Castle P.E., Maucort-Boulch D., and Wheeler C.M. A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion. J Infect Dis 195 11 (2007) 1582-1589
49. Rodriguez AC, Schiffman M, Herrero R, Hildesheim A, Wacholder S. Longitudinal, prospective study of type-specific carcinogenic HPV infections over 7 years in Guanacaste, Costa Rica. Proceedings of the 24th International Papillomavirus Conference and Clinical Workshop, Beijing, China 2007. Abstracts book. Abstract 7B-02.
50. Moscicki A.B., Ellenberg J.H., Farhat S., and Xu J. Persistence of human papillomavirus infection in HIV-infected and -uninfected adolescent girls: risk factors and differences, by phylogenetic type. J Infect Dis 190 1 (2004) 37-45
51. Paavonen J., Jenkins D., Bosch F.X., Naud P., Salmeron J., Wheeler C.M., et al. Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial. Lancet 369 9580 (2007) 2161-2170